Author: Ashish Goyal; E. Fabian Cardozo-Ojeda; Joshua T Schiffer
                    Title: Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response  Document date: 2020_4_14
                    ID: d7stppv5_95
                    
                    Snippet: Heatmaps comparing variance in drug potency measured by in vivo EC50 (x-axis) and timing of treatment initiation (y-axis) for A. Shedding duration, B. viral load area under the curve (AUC) and C. extent of T cell response required for viral elimination. Potent therapy within the first 5 days of infection limits shedding duration and the extent of the T cell response. However, only extremely early therapy during the pre-symptomatic phase of infect.....
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: Heatmaps comparing variance in drug potency measured by in vivo EC50 (x-axis) and timing of treatment initiation (y-axis) for A. Shedding duration, B. viral load area under the curve (AUC) and C. extent of T cell response required for viral elimination. Potent therapy within the first 5 days of infection limits shedding duration and the extent of the T cell response. However, only extremely early therapy during the pre-symptomatic phase of infection lowers viral AUC. Sub-potent therapy given during the extremely early pre-symptomatic stage may extend shedding duration at lower viral loads by limiting the effector cell response.
 
  Search related documents: 
                                Co phrase  search for related documents- AUC curve and drug potency: 1
  - AUC curve and infection limit: 1, 2, 3
  - AUC curve and potent therapy: 1
  - AUC curve and pre symptomatic phase: 1, 2
  - AUC curve and Shedding duration: 1, 2, 3, 4, 5, 6
  - AUC curve and treatment initiation: 1, 2, 3
  - AUC curve and treatment initiation timing: 1, 2, 3
  - AUC curve and viral auc: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
  - AUC curve and viral auc lower: 1
  - AUC curve and viral elimination: 1, 2, 3
  - AUC curve and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
  - AUC curve and viral load area: 1, 2, 3, 4, 5, 6, 7, 8
  - AUC curve viral load area and cell response: 1, 2
  - AUC curve viral load area and drug potency: 1
  - AUC curve viral load area and pre symptomatic phase: 1, 2
  - AUC curve viral load area and Shedding duration: 1, 2, 3
  - AUC curve viral load area and treatment initiation: 1, 2, 3
  - AUC curve viral load area and treatment initiation timing: 1, 2, 3
  - AUC curve viral load area and viral auc: 1, 2, 3, 4, 5, 6, 7, 8
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date